KETOCONAZOLE CREAM, 2%

KETOCONAZOLE CREAM, 2% was reported 15184 times

KETOCONAZOLE CREAM, 2% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPURA SENILE 12 0.0984
1 TARSAL TUNNEL SYNDROME 12 0.0545
2 SEBORRHOEIC DERMATITIS 83 0.0502
3 INTERTRIGO 27 0.0495
4 ASPERGILLUS TEST POSITIVE 15 0.0487
5 CORTISOL INCREASED 30 0.0480
6 TINEA VERSICOLOUR 12 0.0333
7 LENTIGO 14 0.0282
8 TINEA CRURIS 12 0.0241
9 DANDRUFF 52 0.0235
10 BODY TINEA 13 0.0232
11 OTITIS MEDIA ACUTE 16 0.0217
12 SEBORRHOEIC KERATOSIS 31 0.0213
13 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 22 0.0207
14 HYPERPARATHYROIDISM SECONDARY 49 0.0195
15 NEPHROGENIC ANAEMIA 86 0.0185
16 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16 0.0173
17 XEROSIS 21 0.0170
18 TINEA PEDIS 27 0.0169
19 PNEUMONIA MYCOPLASMAL 13 0.0163
20 RESORPTION BONE INCREASED 11 0.0134
21 GUTTATE PSORIASIS 11 0.0134
22 ADRENAL SUPPRESSION 11 0.0130
23 JAW FRACTURE 28 0.0130
24 IMPETIGO 19 0.0127
25 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32 0.0120
26 CONTRAINDICATION TO MEDICAL TREATMENT 18 0.0118
27 VESTIBULAR DISORDER 14 0.0114
28 BONE DEMINERALISATION 12 0.0113
29 ACTINIC KERATOSIS 28 0.0108
30 PUSTULE 25 0.0105
31 PULMONARY GRANULOMA 12 0.0105
32 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 12 0.0100
33 REBOUND ACID HYPERSECRETION 30 0.0099
34 HYPOGONADISM 10 0.0099
35 VERTIGO POSITIONAL 17 0.0097
36 CHEMICAL BURN 11 0.0095
37 TRICHORRHEXIS 26 0.0093
38 PAPULE 62 0.0088
39 FUNGAL SKIN INFECTION 35 0.0087
40 OBSTRUCTIVE SLEEP APNOEA SYNDROME 12 0.0082
41 HAIR TEXTURE ABNORMAL 105 0.0078
42 DEAFNESS BILATERAL 13 0.0076
43 END STAGE RENAL DISEASE 136 0.0074
44 AORTIC ARTERIOSCLEROSIS 19 0.0074
45 CRYPTOCOCCOSIS 12 0.0074
46 PRODUCT ADMINISTRATION INTERRUPTED 57 0.0073
47 PROSTATE CANCER METASTATIC 24 0.0072
48 SKIN PAPILLOMA 27 0.0067
49 SKIN WEEPING 24 0.0067
50 BLOOD IMMUNOGLOBULIN E INCREASED 16 0.0066
51 ESSENTIAL HYPERTENSION 12 0.0066
52 CHEST X-RAY ABNORMAL 20 0.0065
53 SKIN PLAQUE 55 0.0065
54 ADRENAL INSUFFICIENCY 79 0.0065
55 ECONOMIC PROBLEM 98 0.0065
56 CHRONIC KIDNEY DISEASE 488 0.0064
57 DERMATITIS PSORIASIFORM 13 0.0064
58 MELANOCYTIC NAEVUS 27 0.0062
59 ADRENOCORTICAL INSUFFICIENCY ACUTE 12 0.0061
60 BLOOD CHLORIDE DECREASED 15 0.0058
61 PRE-EXISTING CONDITION IMPROVED 36 0.0058
62 ANHEDONIA 151 0.0057
63 PROSTATIC SPECIFIC ANTIGEN INCREASED 79 0.0057
64 THROMBOPHLEBITIS SUPERFICIAL 17 0.0056
65 ROSACEA 26 0.0056
66 NOSOCOMIAL INFECTION 12 0.0054
67 RHINITIS ALLERGIC 24 0.0054
68 BACTERIAL TEST POSITIVE 12 0.0054
69 MIXED LIVER INJURY 16 0.0053
70 HAIR COLOUR CHANGES 65 0.0052
71 MACULE 14 0.0050
72 CLOSTRIDIUM TEST POSITIVE 11 0.0050
73 SKIN HYPERTROPHY 14 0.0050
74 LIP PAIN 14 0.0049
75 OTITIS MEDIA 16 0.0048
76 LUMBAR SPINAL STENOSIS 14 0.0048
77 OSTEITIS 12 0.0048
78 PSORIASIS 612 0.0047
79 PRURITUS GENITAL 11 0.0047
80 LOOSE TOOTH 15 0.0047
81 LUNG CONSOLIDATION 13 0.0046
82 SEBORRHOEA 17 0.0046
83 LEG AMPUTATION 19 0.0046
84 SCAB 52 0.0046
85 DERMAL CYST 11 0.0045
86 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0045
87 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
88 IDIOPATHIC INTRACRANIAL HYPERTENSION 10 0.0044
89 DERMATITIS 93 0.0044
90 BONE LESION 16 0.0044
91 HEPATITIS FULMINANT 13 0.0044
92 HYPERKERATOSIS 24 0.0043
93 SPINAL OSTEOARTHRITIS 38 0.0043
94 BLOOD CREATININE DECREASED 13 0.0041
95 HEPATOSPLENOMEGALY 10 0.0039
96 THERAPEUTIC PRODUCT INEFFECTIVE 15 0.0039
97 ONYCHOMYCOSIS 17 0.0039
98 HYPERLIPIDAEMIA 46 0.0038
99 SKIN EXFOLIATION 324 0.0038
100 DIVERTICULUM 27 0.0038
101 SLEEP APNOEA SYNDROME 72 0.0038
102 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
103 OSTEOPENIA 57 0.0038
104 CHRONIC SINUSITIS 14 0.0037
105 DERMATITIS CONTACT 42 0.0037
106 DERMATITIS ATOPIC 194 0.0037
107 SWELLING OF EYELID 23 0.0037
108 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
109 SKIN INFECTION 41 0.0037
110 SPUTUM DISCOLOURED 34 0.0036
111 METASTASES TO SPINE 12 0.0036
112 RENAL TUBULAR NECROSIS 35 0.0036
113 GINGIVITIS 19 0.0035
114 HERPES VIRUS INFECTION 20 0.0035
115 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 189 0.0034
116 FUNGAL INFECTION 113 0.0034
117 SKIN ABRASION 16 0.0034
118 INFUSION SITE HAEMORRHAGE 11 0.0033
119 SKIN MASS 22 0.0033
120 VITAMIN D DEFICIENCY 32 0.0033
121 PURULENT DISCHARGE 14 0.0033
122 SKIN HYPERPIGMENTATION 28 0.0033
123 PRODUCT PHYSICAL CONSISTENCY ISSUE 18 0.0032
124 PRODUCT LABEL ISSUE 22 0.0032
125 APPLICATION SITE DRYNESS 11 0.0032
126 DIASTOLIC DYSFUNCTION 10 0.0032
127 SKIN HAEMORRHAGE 48 0.0032
128 DIABETIC NEUROPATHY 16 0.0032
129 PSORIATIC ARTHROPATHY 131 0.0032
130 BRADYKINESIA 19 0.0032
131 SPINAL FUSION SURGERY 13 0.0032
132 PERIORBITAL SWELLING 18 0.0032
133 HIDRADENITIS 29 0.0032
134 SEASONAL ALLERGY 45 0.0032
135 RENAL CYST 25 0.0031
136 INTERVERTEBRAL DISC DEGENERATION 29 0.0031
137 SUBCUTANEOUS ABSCESS 15 0.0031
138 NAIL DISORDER 27 0.0031
139 SINUS DISORDER 61 0.0031
140 SKIN IRRITATION 141 0.0031
141 PIGMENTATION DISORDER 19 0.0031
142 SKIN LESION 84 0.0031
143 ABSCESS LIMB 13 0.0030
144 UPPER-AIRWAY COUGH SYNDROME 25 0.0030
145 ECZEMA 156 0.0030
146 NEURODERMATITIS 11 0.0030
147 RENAL FAILURE 392 0.0029
148 MULTIPLE ALLERGIES 23 0.0029
149 AFFECTIVE DISORDER 23 0.0029
150 JAW DISORDER 16 0.0029
151 HEPATOTOXICITY 65 0.0029
152 SKIN FISSURES 57 0.0029
153 HYPERTRIGLYCERIDAEMIA 17 0.0029
154 FAILURE TO THRIVE 15 0.0029
155 SKIN SWELLING 25 0.0029
156 TENDERNESS 30 0.0029
157 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
158 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 201 0.0028
159 PROSTATOMEGALY 11 0.0028
160 SKIN DISORDER 93 0.0028
161 PERFORMANCE STATUS DECREASED 13 0.0028
162 SCRATCH 29 0.0027
163 SCOLIOSIS 17 0.0027
164 CYSTITIS HAEMORRHAGIC 11 0.0027
165 APPLICATION SITE PAIN 60 0.0027
166 IMPAIRED GASTRIC EMPTYING 37 0.0027
167 APPLICATION SITE DISCOLOURATION 11 0.0027
168 NEPHROPATHY 25 0.0027
169 APPLICATION SITE EXFOLIATION 11 0.0027
170 SKIN LACERATION 29 0.0027
171 NEUTROPENIC SEPSIS 19 0.0027
172 FURUNCLE 21 0.0026
173 FULL BLOOD COUNT ABNORMAL 28 0.0026
174 APPLICATION SITE SWELLING 13 0.0026
175 BONE DISORDER 47 0.0026
176 DRY SKIN 342 0.0026
177 ARTERIOSCLEROSIS 24 0.0025
178 CARDIAC MURMUR 22 0.0025
179 MULTIPLE INJURIES 16 0.0025
180 DIVERTICULUM INTESTINAL 11 0.0025
181 THERAPY PARTIAL RESPONDER 39 0.0025
182 HYPOKALAEMIA 115 0.0025
183 BLOOD TESTOSTERONE DECREASED 17 0.0025
184 NOCTURIA 30 0.0025
185 DERMATITIS ACNEIFORM 15 0.0025
186 DENTAL CARIES 27 0.0024
187 ARTHROPOD BITE 18 0.0024
188 NERVE INJURY 27 0.0024
189 COMPRESSION FRACTURE 13 0.0024
190 ELECTROLYTE IMBALANCE 28 0.0024
191 EYE DISCHARGE 25 0.0024
192 TRICUSPID VALVE INCOMPETENCE 19 0.0024
193 DRUG INTERACTION 379 0.0024
194 ATELECTASIS 23 0.0024
195 NODULE 31 0.0024
196 TOOTH INFECTION 31 0.0023
197 RENAL FAILURE CHRONIC 18 0.0023
198 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
199 PERIPHERAL VASCULAR DISORDER 12 0.0023
200 ONYCHOCLASIS 16 0.0023
201 ACUTE KIDNEY INJURY 355 0.0023
202 METASTASES TO BONE 38 0.0023
203 HAIR GROWTH ABNORMAL 16 0.0023
204 SENSITIVE SKIN 17 0.0023
205 RENAL INJURY 68 0.0023
206 THERAPEUTIC RESPONSE UNEXPECTED 102 0.0023
207 THERAPEUTIC RESPONSE SHORTENED 75 0.0023
208 TOOTH ABSCESS 23 0.0023
209 PRURITUS 867 0.0023
210 INFUSION SITE EXTRAVASATION 14 0.0022
211 FOOD POISONING 12 0.0022
212 MENINGITIS ASEPTIC 10 0.0022
213 PRODUCT RESIDUE PRESENT 12 0.0022
214 ERECTILE DYSFUNCTION 57 0.0022
215 PSEUDOMONAS INFECTION 19 0.0022
216 OSTEOMYELITIS 40 0.0022
217 SKIN ULCER 57 0.0022
218 FOLLICULITIS 23 0.0022
219 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
220 PRODUCT USE IN UNAPPROVED INDICATION 541 0.0022
221 ORAL DISORDER 16 0.0022
222 ORTHOSTATIC HYPOTENSION 38 0.0022
223 RHABDOMYOLYSIS 91 0.0022
224 JOINT EFFUSION 15 0.0022
225 INCREASED TENDENCY TO BRUISE 20 0.0022
226 BONE DENSITY DECREASED 68 0.0022
227 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
228 CONTRAINDICATED PRODUCT ADMINISTERED 65 0.0021
229 CELLULITIS 108 0.0021
230 PRODUCT COLOUR ISSUE 11 0.0021
231 HYDRONEPHROSIS 16 0.0021
232 INFUSION SITE ERYTHEMA 18 0.0021
233 DECREASED ACTIVITY 23 0.0021
234 EYE INFECTION 24 0.0021
235 HAND FRACTURE 15 0.0021
236 BASAL CELL CARCINOMA 33 0.0021
237 BRAIN FOG 33 0.0021
238 BREAST MASS 14 0.0021
239 PATHOGEN RESISTANCE 19 0.0021
240 EXOSTOSIS 19 0.0021
241 FOOD ALLERGY 16 0.0021
242 APPLICATION SITE PRURITUS 47 0.0021
243 CONCUSSION 16 0.0021
244 INFUSION SITE SWELLING 13 0.0021
245 SLUGGISHNESS 21 0.0021
246 BACTERIAL INFECTION 38 0.0020
247 ROTATOR CUFF SYNDROME 26 0.0020
248 LYMPHOEDEMA 14 0.0020
249 ANEURYSM 10 0.0020
250 OBSESSIVE-COMPULSIVE DISORDER 16 0.0020
251 THERMAL BURN 14 0.0020
252 PAIN OF SKIN 53 0.0020
253 BLOOD SODIUM DECREASED 37 0.0020
254 OSTEOARTHRITIS 83 0.0020
255 URINARY INCONTINENCE 58 0.0020
256 MENISCUS INJURY 12 0.0019
257 RIB FRACTURE 40 0.0019
258 MITRAL VALVE INCOMPETENCE 22 0.0019
259 POST-TRAUMATIC STRESS DISORDER 13 0.0019
260 APPLICATION SITE IRRITATION 24 0.0019
261 SCAR 33 0.0019
262 LUNG INFILTRATION 17 0.0019
263 HOSPICE CARE 19 0.0019
264 LIGAMENT SPRAIN 19 0.0019
265 OSTEOPOROSIS 79 0.0019
266 MAJOR DEPRESSION 14 0.0019
267 MOUTH SWELLING 11 0.0019
268 RASH ERYTHEMATOUS 91 0.0019
269 LOCALISED INFECTION 46 0.0019
270 FOOT FRACTURE 36 0.0019
271 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
272 ECCHYMOSIS 13 0.0019
273 HYPOPHOSPHATAEMIA 14 0.0019
274 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
275 CONJUNCTIVITIS 35 0.0019
276 GINGIVAL PAIN 15 0.0019
277 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
278 HYPERCHOLESTEROLAEMIA 18 0.0019
279 SINUS BRADYCARDIA 18 0.0019
280 CYST 23 0.0019
281 ERYTHEMA OF EYELID 10 0.0018
282 DRY EYE 92 0.0018
283 DECUBITUS ULCER 15 0.0018
284 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 96 0.0018
285 EOSINOPHILIA 32 0.0018
286 DRUG EFFECT LESS THAN EXPECTED 27 0.0018
287 HAIR DISORDER 15 0.0018
288 INJECTION SITE VESICLES 11 0.0018
289 PULMONARY MASS 27 0.0018
290 ANKLE FRACTURE 28 0.0018
291 THERAPY NON-RESPONDER 81 0.0018
292 RASH MACULAR 63 0.0018
293 MUSCULOSKELETAL DISCOMFORT 31 0.0018
294 HAEMORRHOIDS 35 0.0018
295 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
296 SURGERY 105 0.0018
297 EYE PRURITUS 60 0.0018
298 RASH PUSTULAR 13 0.0018
299 POSTOPERATIVE WOUND INFECTION 12 0.0018
300 RASH PRURITIC 96 0.0018
301 EAR INFECTION 47 0.0018
302 MOUTH ULCERATION 37 0.0018
303 RASH 765 0.0018
304 ATRIAL FLUTTER 14 0.0018
305 MICTURITION URGENCY 20 0.0017
306 ERYTHEMA 359 0.0017
307 SKIN DISCOLOURATION 80 0.0017
308 PHOTOPSIA 11 0.0017
309 INTERVERTEBRAL DISC PROTRUSION 38 0.0017
310 OSTEONECROSIS OF JAW 43 0.0017
311 VENTRICULAR EXTRASYSTOLES 18 0.0017
312 VITREOUS FLOATERS 17 0.0017
313 ALOPECIA 339 0.0017
314 BURNING SENSATION 121 0.0017
315 PETECHIAE 18 0.0017
316 FORMICATION 12 0.0017
317 GASTROOESOPHAGEAL REFLUX DISEASE 138 0.0017
318 HICCUPS 14 0.0017
319 APPLICATION SITE VESICLES 11 0.0017
320 PHOTOSENSITIVITY REACTION 28 0.0017
321 OBESITY 27 0.0017
322 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
323 ORAL HERPES 33 0.0017
324 SENSORY DISTURBANCE 27 0.0017
325 LOW DENSITY LIPOPROTEIN INCREASED 13 0.0017
326 PERIPHERAL SWELLING 258 0.0017
327 BONE LOSS 25 0.0017
328 BLOOD POTASSIUM INCREASED 27 0.0017
329 HEPATITIS CHOLESTATIC 10 0.0017
330 BIPOLAR DISORDER 18 0.0017
331 EYE PAIN 93 0.0016
332 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
333 APPLICATION SITE ERYTHEMA 43 0.0016
334 QUALITY OF LIFE DECREASED 22 0.0016
335 CHROMATURIA 37 0.0016
336 VITAMIN D DECREASED 14 0.0016
337 INFUSION SITE PAIN 21 0.0016
338 SINUS CONGESTION 22 0.0016
339 HYPERKALAEMIA 57 0.0016
340 FEELING DRUNK 12 0.0016
341 PHARYNGITIS 20 0.0016
342 URINARY TRACT INFECTION 275 0.0016
343 SUNBURN 12 0.0016
344 TREATMENT FAILURE 133 0.0016
345 TOOTHACHE 29 0.0016
346 SECRETION DISCHARGE 20 0.0016
347 DROOLING 11 0.0016
348 DERMATITIS ALLERGIC 20 0.0016
349 ARTHRITIS 125 0.0016
350 EMPHYSEMA 16 0.0016
351 ADVERSE DRUG REACTION 142 0.0016
352 OCULAR HYPERAEMIA 75 0.0016
353 AORTIC ANEURYSM 12 0.0016
354 DRUG LEVEL INCREASED 26 0.0016
355 NEPHROLITHIASIS 72 0.0016
356 EMOTIONAL DISTRESS 190 0.0016
357 BOWEL MOVEMENT IRREGULARITY 12 0.0016
358 NEOPLASM 18 0.0016
359 GLAUCOMA 30 0.0016
360 BLISTER 87 0.0015
361 LIVER FUNCTION TEST ABNORMAL 45 0.0015
362 INCOHERENT 10 0.0015
363 CARDIOMEGALY 19 0.0015
364 HYPOALBUMINAEMIA 12 0.0015
365 INTENTIONAL DOSE OMISSION 44 0.0015
366 SPINAL OPERATION 19 0.0015
367 TOOTH FRACTURE 17 0.0015
368 PHOTOPHOBIA 29 0.0015
369 CYSTITIS 49 0.0015
370 PULMONARY HAEMORRHAGE 12 0.0015
371 PHARYNGEAL SWELLING 15 0.0015
372 POOR QUALITY SLEEP 33 0.0015
373 RENAL FAILURE ACUTE 65 0.0015
374 DRUG-INDUCED LIVER INJURY 48 0.0015
375 BLOOD POTASSIUM DECREASED 46 0.0015
376 DEAFNESS 40 0.0015
377 PNEUMONIA BACTERIAL 14 0.0015
378 COVID-19 PNEUMONIA 18 0.0015
379 MENTAL STATUS CHANGES 42 0.0015
380 LIMB INJURY 41 0.0015
381 PRODUCT DISTRIBUTION ISSUE 14 0.0015
382 BODY HEIGHT DECREASED 16 0.0015
383 UPPER RESPIRATORY TRACT INFECTION 69 0.0015
384 NEUROPATHY PERIPHERAL 142 0.0015
385 SQUAMOUS CELL CARCINOMA 14 0.0015
386 ASPARTATE AMINOTRANSFERASE INCREASED 79 0.0015
387 DYSPNOEA EXERTIONAL 56 0.0015
388 RESTLESS LEGS SYNDROME 27 0.0015
389 TOOTH DISORDER 33 0.0015
390 MUSCULAR WEAKNESS 168 0.0015
391 SINUSITIS 151 0.0015
392 PRODUCT PACKAGING ISSUE 14 0.0015
393 HYPOTHYROIDISM 47 0.0015
394 ABNORMAL LOSS OF WEIGHT 10 0.0015
395 ANXIETY 417 0.0015
396 OESOPHAGITIS 16 0.0015
397 INITIAL INSOMNIA 15 0.0015
398 OEDEMA 79 0.0015
399 STAPHYLOCOCCAL INFECTION 48 0.0015
400 MYOSITIS 13 0.0014
401 IRRITABLE BOWEL SYNDROME 31 0.0014
402 SCIATICA 23 0.0014
403 EAR PAIN 28 0.0014
404 HYPERTRANSAMINASAEMIA 10 0.0014
405 HEPATIC CIRRHOSIS 27 0.0014
406 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
407 AUTOIMMUNE DISORDER 14 0.0014
408 OSTEONECROSIS 47 0.0014
409 ORAL PAIN 32 0.0014
410 PRODUCTIVE COUGH 68 0.0014
411 CANDIDA INFECTION 24 0.0014
412 BRONCHITIS 105 0.0014
413 SWELLING FACE 92 0.0014
414 PAIN IN JAW 40 0.0014
415 HAEMATOCRIT DECREASED 28 0.0014
416 NERVE COMPRESSION 13 0.0014
417 IRON DEFICIENCY ANAEMIA 13 0.0014
418 EYE IRRITATION 81 0.0014
419 HEPATITIS 36 0.0014
420 CHOLELITHIASIS 46 0.0014
421 BURSITIS 17 0.0014
422 TRANSAMINASES INCREASED 31 0.0014
423 BLOOD CREATININE INCREASED 91 0.0014
424 BLOOD MAGNESIUM DECREASED 12 0.0014
425 PSYCHOLOGICAL TRAUMA 12 0.0014
426 PNEUMOTHORAX 22 0.0014
427 SKIN BURNING SENSATION 99 0.0014
428 CONDITION AGGRAVATED 419 0.0014
429 VASCULITIS 16 0.0014
430 SPINAL DISORDER 13 0.0014
431 GASTROENTERITIS 20 0.0014
432 POLLAKIURIA 57 0.0014
433 HALLUCINATION 103 0.0014
434 SENSORY LOSS 11 0.0014
435 NIGHT SWEATS 44 0.0014
436 NEURALGIA 33 0.0014
437 TEMPERATURE INTOLERANCE 14 0.0014
438 CARPAL TUNNEL SYNDROME 19 0.0014
439 BLINDNESS TRANSIENT 10 0.0014
440 LIVER FUNCTION TEST INCREASED 29 0.0013
441 TOOTH LOSS 28 0.0013
442 DEPRESSION 306 0.0013
443 GALLBLADDER DISORDER 24 0.0013
444 FACIAL PAIN 12 0.0013
445 ABNORMAL FAECES 11 0.0013
446 HEPATIC STEATOSIS 25 0.0013
447 HOT FLUSH 101 0.0013
448 PRODUCT DOSE OMISSION ISSUE 393 0.0013
449 ALANINE AMINOTRANSFERASE INCREASED 82 0.0013
450 ANAL INCONTINENCE 12 0.0013
451 DYSPHONIA 78 0.0013
452 SLEEP DISORDER 94 0.0013
453 INJECTION SITE DISCOMFORT 14 0.0013
454 RHINORRHOEA 86 0.0013
455 HYPOAESTHESIA ORAL 20 0.0013
456 HYPERSOMNIA 38 0.0013
457 JOINT DISLOCATION 14 0.0013
458 LACRIMATION INCREASED 40 0.0013
459 LIP DRY 12 0.0013
460 PRODUCT DOSE OMISSION 86 0.0013
461 HIATUS HERNIA 17 0.0013
462 NO THERAPEUTIC RESPONSE 16 0.0013
463 NASAL CONGESTION 77 0.0013
464 MIGRAINE 125 0.0013
465 PRODUCT DOSE OMISSION IN ERROR 37 0.0013
466 SMALL INTESTINAL OBSTRUCTION 16 0.0013
467 OFF LABEL USE 1134 0.0013
468 CARDIAC FAILURE CONGESTIVE 104 0.0013
469 RASH PAPULAR 29 0.0013
470 ORAL CANDIDIASIS 17 0.0013
471 HYPOPHAGIA 33 0.0013
472 COORDINATION ABNORMAL 18 0.0013
473 APHTHOUS ULCER 10 0.0013
474 TASTE DISORDER 26 0.0013
475 INJECTION SITE DISCOLOURATION 16 0.0013
476 EYE DISORDER 42 0.0013
477 ARTHRALGIA 531 0.0013
478 DYSURIA 47 0.0013
479 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
480 BALANCE DISORDER 110 0.0013
481 PRODUCT USE COMPLAINT 20 0.0013
482 EAR DISCOMFORT 13 0.0013
483 ACNE 96 0.0013
484 FOOT DEFORMITY 14 0.0013
485 LIMB DISCOMFORT 39 0.0013
486 BLOOD PRESSURE ABNORMAL 25 0.0013
487 HEPATIC CYTOLYSIS 16 0.0013
488 CORONARY ARTERY DISEASE 38 0.0013
489 ACUTE MYOCARDIAL INFARCTION 37 0.0013
490 THERAPEUTIC RESPONSE DECREASED 76 0.0013
491 ELECTROCARDIOGRAM QT PROLONGED 45 0.0012
492 ASTHMA 141 0.0012
493 OCULAR DISCOMFORT 14 0.0012
494 FISTULA 14 0.0012
495 DRY MOUTH 101 0.0012
496 INSURANCE ISSUE 19 0.0012
497 OROPHARYNGEAL PAIN 115 0.0012
498 REBOUND EFFECT 14 0.0012
499 DIZZINESS POSTURAL 12 0.0012
500 PHARYNGEAL OEDEMA 19 0.0012
501 FIBROMYALGIA 30 0.0012
502 OEDEMA PERIPHERAL 150 0.0012
503 PLATELET COUNT INCREASED 16 0.0012
504 GASTROINTESTINAL INFECTION 11 0.0012
505 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
506 DELUSION 19 0.0012
507 BLOOD CHOLESTEROL INCREASED 57 0.0012
508 TINNITUS 56 0.0012
509 CARDIOMYOPATHY 18 0.0012
510 OROPHARYNGEAL DISCOMFORT 11 0.0012
511 HEPATIC ENZYME INCREASED 83 0.0012
512 TREMOR 202 0.0012
513 SWOLLEN TONGUE 38 0.0012
514 MASS 17 0.0012
515 WOUND 34 0.0012
516 GENERALISED OEDEMA 15 0.0012
517 METASTASES TO LUNG 14 0.0012
518 ILEUS 15 0.0012
519 SKIN REACTION 17 0.0012
520 CONSTIPATION 263 0.0012
521 OVARIAN CYST 12 0.0012
522 PULMONARY FIBROSIS 23 0.0012
523 FALL 399 0.0012
524 SPINAL PAIN 14 0.0012
525 MALIGNANT MELANOMA 16 0.0012
526 PRODUCT PRESCRIBING ISSUE 26 0.0012
527 UROSEPSIS 11 0.0012
528 DEHYDRATION 159 0.0012
529 PRODUCT USE ISSUE 224 0.0012
530 ABSCESS 19 0.0012
531 PRODUCT PHYSICAL ISSUE 24 0.0012
532 WEIGHT DECREASED 332 0.0012
533 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
534 BLOOD BILIRUBIN INCREASED 32 0.0012
535 ILLNESS 122 0.0012
536 IMPAIRED QUALITY OF LIFE 17 0.0012
537 BLOOD IRON DECREASED 14 0.0012
538 GASTRITIS 31 0.0012
539 OXYGEN SATURATION DECREASED 66 0.0012
540 FLANK PAIN 11 0.0012
541 GOUT 21 0.0012
542 BACK DISORDER 19 0.0012
543 WRIST FRACTURE 14 0.0012
544 DRUG RESISTANCE 30 0.0012
545 THYROID DISORDER 18 0.0012
546 HYPOXIA 41 0.0012
547 DISABILITY 23 0.0012
548 INFECTION 168 0.0012
549 CATARACT 69 0.0012
550 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
551 PROTEINURIA 22 0.0012
552 SEPTIC SHOCK 50 0.0011
553 ACUTE RESPIRATORY FAILURE 22 0.0011
554 COAGULOPATHY 19 0.0011
555 MUSCLE SPASTICITY 14 0.0011
556 HAEMATURIA 39 0.0011
557 URINARY RETENTION 38 0.0011
558 IMMUNE SYSTEM DISORDER 15 0.0011
559 CHOLECYSTECTOMY 13 0.0011
560 HALLUCINATION, VISUAL 24 0.0011
561 SWELLING 106 0.0011
562 VERTIGO 69 0.0011
563 DRUG INEFFECTIVE 1492 0.0011
564 BACK PAIN 263 0.0011
565 HERPES ZOSTER 65 0.0011
566 DYSPEPSIA 111 0.0011
567 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
568 DIALYSIS 16 0.0011
569 RETCHING 24 0.0011
570 BREAST PAIN 12 0.0011
571 INFLAMMATION 58 0.0011
572 JOINT INJURY 24 0.0011
573 MUSCLE SPASMS 206 0.0011
574 PNEUMONIA ASPIRATION 28 0.0011
575 RED BLOOD CELL COUNT DECREASED 32 0.0011
576 BODY TEMPERATURE DECREASED 11 0.0011
577 THERAPEUTIC PRODUCT EFFECT DECREASED 50 0.0011
578 COUGH 313 0.0011
579 INTESTINAL OBSTRUCTION 42 0.0011
580 DIARRHOEA 719 0.0011
581 COGNITIVE DISORDER 52 0.0011
582 MUSCLE TIGHTNESS 18 0.0011
583 DIZZINESS 554 0.0011
584 SPLENOMEGALY 13 0.0011
585 THROMBOCYTOPENIA 124 0.0011
586 FATIGUE 863 0.0011
587 PARANOIA 19 0.0011
588 COVID-19 193 0.0011
589 SALIVARY HYPERSECRETION 11 0.0011
590 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
591 GAIT DISTURBANCE 210 0.0011
592 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
593 IMPAIRED HEALING 36 0.0011
594 EJECTION FRACTION DECREASED 17 0.0011
595 PNEUMONIA 354 0.0011
596 HEART RATE INCREASED 108 0.0011
597 DYSPHAGIA 103 0.0011
598 LUNG DISORDER 53 0.0011
599 EXPOSURE VIA SKIN CONTACT 28 0.0011
600 EATING DISORDER 23 0.0011
601 LEUKOPENIA 54 0.0011
602 SYNCOPE 108 0.0011
603 DIPLOPIA 28 0.0011
604 LOSS OF CONSCIOUSNESS 138 0.0011
605 RESPIRATORY TRACT INFECTION 28 0.0011
606 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
607 ERYTHEMA MULTIFORME 10 0.0011
608 HYPOGLYCAEMIA 52 0.0011
609 GASTROINTESTINAL DISORDER 96 0.0011
610 UNEVALUABLE EVENT 81 0.0011
611 SNEEZING 24 0.0011
612 PANIC ATTACK 39 0.0011
613 DEFORMITY 10 0.0011
614 PRESYNCOPE 26 0.0011
615 BEDRIDDEN 14 0.0011
616 THERAPY INTERRUPTED 76 0.0011
617 HYPOAESTHESIA 159 0.0011
618 HEPATIC FAILURE 32 0.0011
619 ASTHENIA 398 0.0011
620 BONE PAIN 62 0.0011
621 HEPATOCELLULAR INJURY 15 0.0011
622 PULMONARY HYPERTENSION 22 0.0011
623 NECK PAIN 59 0.0011
624 HEADACHE 661 0.0011
625 GASTROENTERITIS VIRAL 19 0.0011
626 BRONCHOSPASM 15 0.0011
627 PRODUCT ODOUR ABNORMAL 11 0.0010
628 ANAEMIA 200 0.0010
629 THROAT IRRITATION 47 0.0010
630 LYMPHADENOPATHY 37 0.0010
631 TOOTH EXTRACTION 13 0.0010
632 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 188 0.0010
633 FLUID RETENTION 53 0.0010
634 CHOLESTASIS 20 0.0010
635 INCONTINENCE 11 0.0010
636 FEEDING DISORDER 21 0.0010
637 MULTIPLE FRACTURES 17 0.0010
638 PAIN 635 0.0010
639 SEPSIS 115 0.0010
640 MOBILITY DECREASED 74 0.0010
641 VENTRICULAR TACHYCARDIA 17 0.0010
642 JOINT STIFFNESS 27 0.0010
643 NEUROTOXICITY 18 0.0010
644 RENAL IMPAIRMENT 86 0.0010
645 HYPERSENSITIVITY 190 0.0010
646 LIP SWELLING 34 0.0010
647 APPLICATION SITE RASH 14 0.0010
648 HEART RATE IRREGULAR 23 0.0010
649 HEPATOMEGALY 10 0.0010
650 GAIT INABILITY 34 0.0010
651 BLOOD UREA INCREASED 17 0.0010
652 FAECES DISCOLOURED 22 0.0010
653 BACK INJURY 11 0.0010
654 HEAD INJURY 32 0.0010
655 JOINT SWELLING 122 0.0010
656 PARAESTHESIA 159 0.0010
657 DIVERTICULITIS 28 0.0010
658 ORAL DISCOMFORT 14 0.0010
659 HALLUCINATION, AUDITORY 16 0.0010
660 STOMATITIS 61 0.0010
661 HUNGER 14 0.0010
662 PAIN IN EXTREMITY 296 0.0010
663 HAEMATOMA 26 0.0010
664 JAUNDICE 27 0.0010
665 EPISTAXIS 75 0.0010
666 AGEUSIA 25 0.0010
667 DYSPNOEA 567 0.0010
668 BRAIN INJURY 10 0.0010
669 HEART RATE DECREASED 35 0.0010
670 WHEEZING 59 0.0010
671 EYE SWELLING 37 0.0010
672 MYALGIA 169 0.0010
673 CHEST PAIN 184 0.0010
674 FULL BLOOD COUNT DECREASED 20 0.0010
675 DISEASE PROGRESSION 117 0.0010
676 CONTUSION 95 0.0010
677 SYSTEMIC LUPUS ERYTHEMATOSUS 35 0.0010
678 DYSKINESIA 40 0.0010
679 INSOMNIA 262 0.0010
680 DISCOMFORT 60 0.0010
681 VISION BLURRED 135 0.0010
682 TYPE 2 DIABETES MELLITUS 33 0.0010
683 HYPERCALCAEMIA 12 0.0010
684 LYMPHOMA 15 0.0010
685 FEELING COLD 27 0.0010
686 LIVER DISORDER 43 0.0010
687 BLOOD PRESSURE INCREASED 148 0.0010
688 HAEMOPTYSIS 27 0.0010
689 IMPAIRED DRIVING ABILITY 11 0.0010
690 MIDDLE INSOMNIA 18 0.0010
691 SOMNOLENCE 194 0.0010
692 THROAT TIGHTNESS 26 0.0010
693 HEAD DISCOMFORT 17 0.0010
694 TACHYCARDIA 85 0.0010
695 DYSARTHRIA 36 0.0010
696 MOOD ALTERED 26 0.0010
697 INJURY 67 0.0010
698 PLEURAL EFFUSION 58 0.0010
699 VISUAL IMPAIRMENT 118 0.0010
700 NAUSEA 753 0.0010
701 INFLUENZA 106 0.0009
702 NASOPHARYNGITIS 175 0.0009
703 DRUG ADMINISTERED AT INAPPROPRIATE SITE 10 0.0009
704 BLOOD PRESSURE DECREASED 63 0.0009
705 GASTRIC ULCER 18 0.0009
706 ATRIAL FIBRILLATION 92 0.0009
707 DIABETES MELLITUS 72 0.0009
708 HYPERTENSION 200 0.0009
709 ULCER 15 0.0009
710 BRADYCARDIA 50 0.0009
711 LEUKOCYTOSIS 17 0.0009
712 IMMUNODEFICIENCY 14 0.0009
713 ABDOMINAL DISTENSION 98 0.0009
714 ARTHROPATHY 52 0.0009
715 MYDRIASIS 12 0.0009
716 DYSTONIA 18 0.0009
717 MUSCULOSKELETAL STIFFNESS 81 0.0009
718 CHOLECYSTITIS 11 0.0009
719 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
720 TARDIVE DYSKINESIA 26 0.0009
721 DECREASED APPETITE 214 0.0009
722 LYMPHOPENIA 13 0.0009
723 SUICIDAL IDEATION 84 0.0009
724 FLATULENCE 52 0.0009
725 PALPITATIONS 107 0.0009
726 URTICARIA 153 0.0009
727 MUSCLE TWITCHING 21 0.0009
728 PULMONARY CONGESTION 12 0.0009
729 MEMORY IMPAIRMENT 125 0.0009
730 CONFUSIONAL STATE 147 0.0009
731 ABNORMAL BEHAVIOUR 36 0.0009
732 DEEP VEIN THROMBOSIS 59 0.0009
733 AMNESIA 59 0.0009
734 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
735 ABDOMINAL DISCOMFORT 152 0.0009
736 MUSCULOSKELETAL CHEST PAIN 14 0.0009
737 MOVEMENT DISORDER 29 0.0009
738 PARAESTHESIA ORAL 13 0.0009
739 SEIZURE 104 0.0009
740 MENTAL DISORDER 39 0.0009
741 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
742 WEIGHT INCREASED 199 0.0009
743 HAEMOGLOBIN DECREASED 91 0.0009
744 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
745 POST PROCEDURAL COMPLICATION 17 0.0009
746 HYPERGLYCAEMIA 32 0.0009
747 MUSCULOSKELETAL PAIN 46 0.0009
748 TREATMENT NONCOMPLIANCE 48 0.0009
749 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
750 BLOOD PRESSURE FLUCTUATION 21 0.0009
751 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
752 DEPRESSED MOOD 46 0.0009
753 RESPIRATORY DISTRESS 24 0.0009
754 DRUG INTOLERANCE 84 0.0009
755 LETHARGY 50 0.0009
756 KIDNEY INFECTION 17 0.0009
757 BLOOD GLUCOSE ABNORMAL 16 0.0009
758 PULMONARY EMBOLISM 82 0.0009
759 HYPOMAGNESAEMIA 12 0.0009
760 APHONIA 12 0.0009
761 THINKING ABNORMAL 16 0.0009
762 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
763 HYPOTENSION 171 0.0009
764 COLD SWEAT 15 0.0009
765 MANIA 14 0.0009
766 LYMPHOCYTE COUNT DECREASED 15 0.0008
767 HYPERHIDROSIS 109 0.0008
768 SINUS TACHYCARDIA 12 0.0008
769 DEVICE RELATED INFECTION 13 0.0008
770 FEBRILE NEUTROPENIA 56 0.0008
771 BLOOD URINE PRESENT 16 0.0008
772 VIRAL INFECTION 28 0.0008
773 PRODUCT ADMINISTRATION ERROR 17 0.0008
774 MUCOSAL INFLAMMATION 22 0.0008
775 SPEECH DISORDER 44 0.0008
776 THIRST 15 0.0008
777 MACULAR DEGENERATION 10 0.0008
778 SKIN CANCER 18 0.0008
779 BLOOD GLUCOSE DECREASED 40 0.0008
780 GLYCOSYLATED HAEMOGLOBIN INCREASED 21 0.0008
781 VOMITING 388 0.0008
782 DEMENTIA 23 0.0008
783 DYSSTASIA 24 0.0008
784 RESPIRATORY TRACT CONGESTION 13 0.0008
785 AGITATION 60 0.0008
786 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
787 ACCIDENTAL EXPOSURE TO PRODUCT 84 0.0008
788 RASH GENERALISED 21 0.0008
789 INTENTIONAL PRODUCT USE ISSUE 71 0.0008
790 RASH MACULO-PAPULAR 18 0.0008
791 AGRANULOCYTOSIS 15 0.0008
792 INJECTION SITE PRURITUS 54 0.0008
793 CORONARY ARTERY OCCLUSION 11 0.0008
794 PRESCRIBED UNDERDOSE 16 0.0008
795 CHEST DISCOMFORT 82 0.0008
796 SPINAL FRACTURE 16 0.0008
797 ABNORMAL DREAMS 22 0.0008
798 INJECTION SITE SWELLING 61 0.0008
799 RENAL DISORDER 37 0.0008
800 FRACTURE 15 0.0008
801 ABDOMINAL PAIN UPPER 163 0.0008
802 DRUG ERUPTION 14 0.0008
803 MUSCLE ATROPHY 10 0.0008
804 FEELING JITTERY 15 0.0008
805 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
806 INTRAOCULAR PRESSURE INCREASED 10 0.0008
807 ABDOMINAL PAIN 182 0.0008
808 BLINDNESS UNILATERAL 11 0.0008
809 HIP FRACTURE 25 0.0008
810 ANOREXIA 10 0.0008
811 TENDONITIS 12 0.0008
812 LIVER INJURY 19 0.0008
813 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
814 THROMBOSIS 62 0.0008
815 PELVIC PAIN 14 0.0008
816 RESPIRATORY FAILURE 56 0.0008
817 FEELING ABNORMAL 184 0.0008
818 GASTROINTESTINAL HAEMORRHAGE 64 0.0008
819 RESTLESSNESS 28 0.0008
820 INJECTION SITE BRUISING 61 0.0008
821 KNEE ARTHROPLASTY 16 0.0008
822 CARDIAC DISORDER 71 0.0008
823 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
824 FEELING HOT 46 0.0007
825 INJECTION SITE PAIN 230 0.0007
826 MALAISE 326 0.0007
827 THERAPY CESSATION 38 0.0007
828 PYREXIA 256 0.0007
829 HYPOCALCAEMIA 14 0.0007
830 METASTASES TO LIVER 13 0.0007
831 HOSPITALISATION 113 0.0007
832 BODY TEMPERATURE INCREASED 15 0.0007
833 PALLOR 20 0.0007
834 ANGINA PECTORIS 21 0.0007
835 GINGIVAL BLEEDING 10 0.0007
836 INJECTION SITE WARMTH 15 0.0007
837 METABOLIC ACIDOSIS 23 0.0007
838 CHILLS 84 0.0007
839 DYSGEUSIA 53 0.0007
840 NEUTROPENIA 97 0.0007
841 NEUTROPHIL COUNT DECREASED 29 0.0007
842 ACCIDENTAL OVERDOSE 26 0.0007
843 ADVERSE EVENT 65 0.0007
844 FREQUENT BOWEL MOVEMENTS 19 0.0007
845 UPPER LIMB FRACTURE 14 0.0007
846 RESPIRATORY DISORDER 21 0.0007
847 APHASIA 21 0.0007
848 CARDIO-RESPIRATORY ARREST 29 0.0007
849 INJECTION SITE URTICARIA 17 0.0007
850 EXPIRED PRODUCT ADMINISTERED 23 0.0007
851 NERVOUSNESS 36 0.0007
852 DISTURBANCE IN ATTENTION 37 0.0007
853 MALIGNANT NEOPLASM PROGRESSION 70 0.0007
854 DISORIENTATION 27 0.0007
855 INFUSION RELATED REACTION 45 0.0007
856 ANGIOEDEMA 30 0.0007
857 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
858 DRUG PRESCRIBING ERROR 13 0.0007
859 HYPOACUSIS 29 0.0007
860 NERVOUS SYSTEM DISORDER 21 0.0007
861 HERNIA 13 0.0007
862 PRODUCT PRESCRIBING ERROR 16 0.0007
863 COLON CANCER 10 0.0007
864 HEPATIC FUNCTION ABNORMAL 25 0.0007
865 PLASMA CELL MYELOMA 26 0.0007
866 WHITE BLOOD CELL COUNT DECREASED 72 0.0007
867 DELIRIUM 23 0.0007
868 COLITIS 25 0.0007
869 PLATELET COUNT DECREASED 70 0.0007
870 IMPAIRED WORK ABILITY 14 0.0007
871 INJECTION SITE ERYTHEMA 81 0.0007
872 BLOOD GLUCOSE INCREASED 123 0.0007
873 ANAPHYLACTIC REACTION 36 0.0007
874 PERICARDIAL EFFUSION 15 0.0006
875 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
876 PANCYTOPENIA 36 0.0006
877 WITHDRAWAL SYNDROME 27 0.0006
878 INTENTIONAL PRODUCT MISUSE 56 0.0006
879 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
880 PRODUCT PREPARATION ERROR 13 0.0006
881 FEAR 17 0.0006
882 LOCAL SWELLING 11 0.0006
883 MUSCULOSKELETAL DISORDER 12 0.0006
884 STEVENS-JOHNSON SYNDROME 14 0.0006
885 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
886 LOWER LIMB FRACTURE 12 0.0006
887 PANCREATITIS 33 0.0006
888 HYPONATRAEMIA 35 0.0006
889 ENCEPHALOPATHY 15 0.0006
890 PRURITUS GENERALISED 13 0.0006
891 CARDIAC ARREST 49 0.0006
892 HAEMORRHAGE 61 0.0006
893 INFLUENZA LIKE ILLNESS 48 0.0006
894 DIABETIC KETOACIDOSIS 14 0.0006
895 GASTRIC DISORDER 20 0.0006
896 IRRITABILITY 35 0.0006
897 GYNAECOMASTIA 18 0.0006
898 HAEMATOCHEZIA 32 0.0006
899 PERITONITIS 12 0.0006
900 NIGHTMARE 20 0.0006
901 MENTAL IMPAIRMENT 14 0.0006
902 C-REACTIVE PROTEIN INCREASED 21 0.0006
903 PSYCHOTIC DISORDER 17 0.0006
904 DRUG EFFECT DECREASED 31 0.0006
905 ROAD TRAFFIC ACCIDENT 24 0.0006
906 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
907 ARRHYTHMIA 27 0.0006
908 ERUCTATION 11 0.0006
909 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115 0.0006
910 PRODUCT QUALITY ISSUE 77 0.0006
911 CHOKING 11 0.0006
912 GENERAL PHYSICAL HEALTH DETERIORATION 65 0.0006
913 CEREBROVASCULAR ACCIDENT 95 0.0006
914 FLUSHING 57 0.0006
915 RECTAL HAEMORRHAGE 24 0.0006
916 PULMONARY OEDEMA 25 0.0006
917 ABDOMINAL PAIN LOWER 14 0.0006
918 PNEUMONITIS 15 0.0006
919 INTENTIONAL SELF-INJURY 11 0.0005
920 INCORRECT DOSE ADMINISTERED 123 0.0005
921 GLOSSODYNIA 12 0.0005
922 PANCREATITIS ACUTE 12 0.0005
923 PRODUCT AVAILABILITY ISSUE 12 0.0005
924 ABASIA 13 0.0005
925 EXTRAPYRAMIDAL DISORDER 13 0.0005
926 INJECTION SITE RASH 16 0.0005
927 AGGRESSION 26 0.0005
928 EMOTIONAL DISORDER 16 0.0005
929 HAEMATEMESIS 13 0.0005
930 RHEUMATOID ARTHRITIS 58 0.0005
931 MULTIPLE SCLEROSIS RELAPSE 35 0.0005
932 LABORATORY TEST ABNORMAL 15 0.0005
933 PRODUCT DISPENSING ERROR 11 0.0005
934 SEDATION 13 0.0005
935 INJECTION SITE REACTION 34 0.0005
936 UNDERDOSE 36 0.0005
937 EXPOSURE DURING PREGNANCY 30 0.0005
938 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
939 ASCITES 14 0.0005
940 ANGER 16 0.0005
941 CONVULSION 27 0.0005
942 DRUG DOSE OMISSION 77 0.0005
943 NEOPLASM MALIGNANT 31 0.0005
944 DISEASE RECURRENCE 22 0.0005
945 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
946 MULTIPLE SCLEROSIS 22 0.0005
947 NEOPLASM PROGRESSION 16 0.0005
948 INJECTION SITE MASS 17 0.0005
949 EPILEPSY 14 0.0005
950 PROSTATE CANCER 36 0.0004
951 COLITIS ULCERATIVE 20 0.0004
952 CRYING 16 0.0004
953 LUNG NEOPLASM MALIGNANT 18 0.0004
954 VAGINAL HAEMORRHAGE 19 0.0004
955 DEATH 376 0.0004
956 CARDIAC FAILURE 35 0.0004
957 MYOCARDIAL INFARCTION 76 0.0004
958 DEVICE ISSUE 39 0.0004
959 ABORTION SPONTANEOUS 17 0.0004
960 FEMUR FRACTURE 13 0.0004
961 EXTRA DOSE ADMINISTERED 17 0.0004
962 DRUG EFFECT INCOMPLETE 15 0.0004
963 ILL-DEFINED DISORDER 24 0.0004
964 CARDIOVASCULAR DISORDER 10 0.0004
965 CEREBRAL HAEMORRHAGE 14 0.0004
966 ANAPHYLACTIC SHOCK 10 0.0004
967 PRODUCT SUBSTITUTION ISSUE 22 0.0004
968 SUICIDE ATTEMPT 23 0.0004
969 NEEDLE ISSUE 11 0.0004
970 VISUAL ACUITY REDUCED 12 0.0004
971 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
972 NO ADVERSE EVENT 64 0.0004
973 DRUG EXPOSURE DURING PREGNANCY 12 0.0004
974 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
975 MOOD SWINGS 11 0.0003
976 INJECTION SITE HAEMORRHAGE 26 0.0003
977 BLINDNESS 12 0.0003
978 INTERSTITIAL LUNG DISEASE 14 0.0003
979 DEVICE MALFUNCTION 20 0.0003
980 DEVICE LEAKAGE 11 0.0003
981 TOXICITY TO VARIOUS AGENTS 41 0.0002
982 OVERDOSE 52 0.0002
983 MEDICATION ERROR 13 0.0002
984 PRODUCT STORAGE ERROR 19 0.0002
985 BREAST CANCER 18 0.0002
986 INTENTIONAL OVERDOSE 12 0.0002
987 DRUG WITHDRAWAL SYNDROME 15 0.0002
988 DRUG DEPENDENCE 24 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
990 DRUG DOSE OMISSION BY DEVICE 10 0.0001